Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Tyrosine kinase inhibitors in the treatment of polycythemia vera and related conditions. Danish Society of Hematology].

Ugeskrift for laeger - 17 Mar 2008

Larsen Thomas Stauffer, Hasselbalch Hans Carl

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Janus Kinase 2
Share to Mutation
Share to Myeloproliferative Disorders
Share to Polycythemia Vera

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Protein Kinase Inhibitors

Source

Identifiers

PMID: 18397649

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Tyrosine kinase inhibitors in the treatment of polycythemia vera and related conditions. Danish Society of Hematology].PMID 18397649Read ↗

JAK2 mutations in polycythemia vera--molecular mechanisms and clinical applications.Semantic proximity Read ↗

[Abnormal activation of tyrosine kinases and its role in the pathogenesis of hematological malignancies - review].Semantic proximity Read ↗

Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses.Semantic proximity Read ↗

[Clinical features and gene mutation status of polycythemia vera and essential thrombocythemia in Japan].Semantic proximity Read ↗

The advantages and risks of ruxolitinib for the treatment of polycythemia vera.Semantic proximity Read ↗

[The present status of, and problems with the development of FLT3 kinase inhibitors].Semantic proximity Read ↗

[New therapeutic option for leukemia patients, with FLT3/Aurora kinase inhibitor, KW-2449: strategy and comparison with other kinase inhibitors].Semantic proximity Read ↗

[Selective tyrosine kinase inhibitor imatinib (STI571) in haematological and oncological disease].Semantic proximity Read ↗

Mechanism of Action of Ropeginterferon Alfa-2b in Polycythemia Vera TreatmentSemantic proximity Read ↗

Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspectiveSemantic proximity Read ↗

[Polycythemia vera developed after a major molecular response to imatinib mesylate treatment in a patient with chronic myelogenous leukemia].Semantic proximity Read ↗

Givinostat: an emerging treatment for polycythemia vera.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.